Skip to main content

A Trial of Directly Observed and Long-term Varenicline

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Trial of Directly Observed and Long-term Varenicline

Assessing the Efficacy of Virtual Reality Analgesia (VRA) in Pediatric Patients for Pain Control

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Assessing the Efficacy of Virtual Reality Analgesia (VRA) in Pediatric Patients for Pain Control

A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer

Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma

Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma

Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery

A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer

Intravenous Gammaglobulin for Sickle Cell Pain Crises

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Intravenous Gammaglobulin for Sickle Cell Pain Crises

Reproductive Health Program in Patients With Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Reproductive Health Program in Patients With Cancer

Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 250
  • Page 251
  • Page 252
  • Page 253
  • Page 254
  • Page 255
  • Page 256
  • Page 257
  • Page 258
  • …
  • Next page Next
  • Last page Last
Subscribe to